253 related articles for article (PubMed ID: 24018645)
1. RAS mutation status predicts survival and patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases.
Vauthey JN; Zimmitti G; Kopetz SE; Shindoh J; Chen SS; Andreou A; Curley SA; Aloia TA; Maru DM
Ann Surg; 2013 Oct; 258(4):619-26; discussion 626-7. PubMed ID: 24018645
[TBL] [Abstract][Full Text] [Related]
2. Deleterious Effect of RAS and Evolutionary High-risk TP53 Double Mutation in Colorectal Liver Metastases.
Chun YS; Passot G; Yamashita S; Nusrat M; Katsonis P; Loree JM; Conrad C; Tzeng CD; Xiao L; Aloia TA; Eng C; Kopetz SE; Lichtarge O; Vauthey JN
Ann Surg; 2019 May; 269(5):917-923. PubMed ID: 28767562
[TBL] [Abstract][Full Text] [Related]
3. Prospective Study of Perioperative Circulating Tumor DNA Dynamics in Patients Undergoing Hepatectomy for Colorectal Liver Metastases.
Newhook TE; Overman MJ; Chun YS; Dasari A; Tzeng CD; Cao HST; Raymond V; Parseghian C; Johnson B; Nishioka Y; Kawaguchi Y; Uppal A; Vreeland TJ; Jaimovich A; Arvide EM; Cristo JV; Wei SH; Raghav KP; Morris VK; Lee JE; Kopetz S; Vauthey JN
Ann Surg; 2023 May; 277(5):813-820. PubMed ID: 35797554
[TBL] [Abstract][Full Text] [Related]
4. Embryonic Origin of Primary Colon Cancer Predicts Pathologic Response and Survival in Patients Undergoing Resection for Colon Cancer Liver Metastases.
Yamashita S; Brudvik KW; Kopetz SE; Maru D; Clarke CN; Passot G; Conrad C; Chun YS; Aloia TA; Vauthey JN
Ann Surg; 2018 Mar; 267(3):514-520. PubMed ID: 28002060
[TBL] [Abstract][Full Text] [Related]
5. Prognostic assessment of resected colorectal liver metastases integrating pathological features, RAS mutation and Immunoscore.
Baldin P; Van den Eynde M; Mlecnik B; Bindea G; Beniuga G; Carrasco J; Haicheur N; Marliot F; Lafontaine L; Fredriksen T; Lanthier N; Hubert C; Navez B; Huyghe N; Pagès F; Jouret-Mourin A; Galon J; Komuta M
J Pathol Clin Res; 2021 Jan; 7(1):27-41. PubMed ID: 32902189
[TBL] [Abstract][Full Text] [Related]
6. Pre-hepatectomy dynamic circulating tumor DNA to predict pathologic response to preoperative chemotherapy and post-hepatectomy recurrence in patients with colorectal liver metastases.
Liu M; Bao Q; Zhao T; Huang L; Zhang D; Wang Y; Yan X; Wang H; Jin K; Liu W; Wang K; Xing B
Hepatol Int; 2024 Jun; 18(3):1029-1039. PubMed ID: 38427145
[TBL] [Abstract][Full Text] [Related]
7. BRAF mutations and survival with surgery for colorectal liver metastases: A systematic review and meta-analysis.
Petrelli F; Arru M; Colombo S; Cavallone M; Cribiu' FM; Villardita V; Floris P; Digiesi L; Severgnini G; Moraes MT; Conti B; Celotti A; Viti M; Sozzi A
Eur J Surg Oncol; 2024 Jun; 50(6):108306. PubMed ID: 38603866
[TBL] [Abstract][Full Text] [Related]
8. Remnant Liver Ischemia as a Prognostic Factor for Cancer-Specific Survival After Resection of Colorectal Liver Metastases.
Yamashita S; Venkatesan AM; Mizuno T; Aloia TA; Chun YS; Lee JE; Vauthey JN; Conrad C
JAMA Surg; 2017 Oct; 152(10):e172986. PubMed ID: 28854316
[TBL] [Abstract][Full Text] [Related]
9. The effect of hepatic steatosis on survival following resection of colorectal liver metastases in patients without preoperative chemotherapy.
Parkin E; O'Reilly DA; Adam R; Kaiser GM; Laurent C; Elias D; Capussotti L; Renehan AG;
HPB (Oxford); 2013 Jun; 15(6):463-72. PubMed ID: 23458109
[TBL] [Abstract][Full Text] [Related]
10. TP53 Alteration and Its Effect on Pathologic Response Are Associated with Survival after Resection of Colorectal Liver Metastases.
Maki H; Haddad A; Ayabe RI; Lendoire M; Khanduri I; Maru DM; Vauthey JN
J Gastrointest Surg; 2023 Nov; 27(11):2597-2600. PubMed ID: 37553514
[TBL] [Abstract][Full Text] [Related]
11. The association between KRAS and histopathological growth patterns and the impact on resection margins around vasculature and bile ducts in colorectal liver metastases.
Wong P; Wong GYM; Toon CW; Chapuis P; Hugh TJ
ANZ J Surg; 2024 Apr; 94(4):560-565. PubMed ID: 38366706
[TBL] [Abstract][Full Text] [Related]
12. Kras mutation is a marker of worse oncologic outcomes after percutaneous radiofrequency ablation of colorectal liver metastases.
Shady W; Petre EN; Vakiani E; Ziv E; Gonen M; Brown KT; Kemeny NE; Solomon SB; Solit DB; Sofocleous CT
Oncotarget; 2017 Sep; 8(39):66117-66127. PubMed ID: 29029497
[TBL] [Abstract][Full Text] [Related]
13. Evolving survival gains in patients with young-onset colorectal cancer and synchronous resectable liver metastases.
Maki H; Haddad A; Lendoire M; Newhook TE; Peacock O; Bednarski BK; Konishi T; Vauthey JN; You YN
Eur J Surg Oncol; 2024 Apr; 50(4):108057. PubMed ID: 38461567
[TBL] [Abstract][Full Text] [Related]
14. Lymph-node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: the phase 1 AMPLIFY-201 trial.
Pant S; Wainberg ZA; Weekes CD; Furqan M; Kasi PM; Devoe CE; Leal AD; Chung V; Basturk O; VanWyk H; Tavares AM; Seenappa LM; Perry JR; Kheoh T; McNeil LK; Welkowsky E; DeMuth PC; Haqq CM; O'Reilly EM
Nat Med; 2024 Feb; 30(2):531-542. PubMed ID: 38195752
[TBL] [Abstract][Full Text] [Related]
15. Somatic Mutations in Surgically Treated Colorectal Liver Metastases: An Overview.
Wang J; Botvinov J; Bhatt AJ; Beyer K; Kreis ME; Adam M; Alseidi A; Margonis GA
Cells; 2024 Apr; 13(8):. PubMed ID: 38667294
[TBL] [Abstract][Full Text] [Related]
16. Meta-analysis of KRAS mutations and survival after resection of colorectal liver metastases.
Brudvik KW; Kopetz SE; Li L; Conrad C; Aloia TA; Vauthey JN
Br J Surg; 2015 Sep; 102(10):1175-83. PubMed ID: 26206254
[TBL] [Abstract][Full Text] [Related]
17. Incidence and prognostic impact of KRAS and BRAF mutation in patients undergoing liver surgery for colorectal metastases.
Karagkounis G; Torbenson MS; Daniel HD; Azad NS; Diaz LA; Donehower RC; Hirose K; Ahuja N; Pawlik TM; Choti MA
Cancer; 2013 Dec; 119(23):4137-44. PubMed ID: 24104864
[TBL] [Abstract][Full Text] [Related]
18. KRAS mutation influences recurrence patterns in patients undergoing hepatic resection of colorectal metastases.
Kemeny NE; Chou JF; Capanu M; Gewirtz AN; Cercek A; Kingham TP; Jarnagin WR; Fong YC; DeMatteo RP; Allen PJ; Shia J; Ang C; Vakiani E; D'Angelica MI
Cancer; 2014 Dec; 120(24):3965-71. PubMed ID: 25155157
[TBL] [Abstract][Full Text] [Related]
19. RAS mutations affect pattern of metastatic spread and increase propensity for brain metastasis in colorectal cancer.
Yaeger R; Cowell E; Chou JF; Gewirtz AN; Borsu L; Vakiani E; Solit DB; Rosen N; Capanu M; Ladanyi M; Kemeny N
Cancer; 2015 Apr; 121(8):1195-203. PubMed ID: 25491172
[TBL] [Abstract][Full Text] [Related]
20. RAS mutations predict radiologic and pathologic response in patients treated with chemotherapy before resection of colorectal liver metastases.
Zimmitti G; Shindoh J; Mise Y; Kopetz S; Loyer EM; Andreou A; Cooper AB; Kaur H; Aloia TA; Maru DM; Vauthey JN
Ann Surg Oncol; 2015 Mar; 22(3):834-842. PubMed ID: 25227306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
